MASI - マシモ (Masimo Corporation) マシモ



symbol MASI
会社名 Masimo Corp. (マシモ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 マシモ(Masimo Corporation) は医療技術企業であり、非侵襲患者モニタリング製品を開発・製造・販売する。同社の事業はマシモ信号抽出技術(SET)パルスオキシメトリーと知られる測定スルーモーションおよび低灌流パルスオキシメトリーモニタリングである。製品には光学特性、光学臓器酸素濃度測定、電気、脳機能モニタリング、音響呼吸モニタリング、呼気モニタリングなどの血液成分の非侵襲的モニタリングが含まれる。同社はまたRoot患者のモニタリングおよび接続プラットフォーム、Radical-7ベッドサイドとポータブル患者モニタ、Radius-7ウェアラブル無線患者モニタを開発する。同社はPatient SafetyNetリモート患者監視監視システムを提供する。これにより、患者はパーソナルコンピュータベースのモニタまたはポケベル、ボイスオーバーインターネットプロトコル(IP)電話、スマートフォンを通じてケア提供者によって監視される。   マシモは、米国の医療技術企業。非侵襲的患者監視製品を開発、製造、売買に従事する。患者監視ソリュ―ションは、一般的にはモニタ―や回路基板とセンサ―に組み込まれる。主にに直接パ―トナ―代理店もしくは元の機器メ―カ―を通じて、病院、救急医療サ―ビス・プロバイダ―、医師、獣医師、介護施設や消費者に同社製品を販売する。   Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
本社所在地 52 Discovery Irvine CA 92618 USA
代表者氏名 Joseph E. Kiani ジョセフ・E・キアニ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 949-297-7000
設立年月日 32629
市場名 NASDAQ National Market System
ipoyear 2007年
従業員数 4600人
EBITDA EBITDA(百万ドル) 233.99600
終値(lastsale) 119.46
時価総額(marketcap) 6232234889.76
時価総額 時価総額(百万ドル) 650.162
売上高 売上高(百万ドル) 843.44700
企業価値(EV) 企業価値(EV)(百万ドル) 5620.515
当期純利益 当期純利益(百万ドル) 207.08600
決算概要 決算概要 BRIEF: For the 26 weeks ended 30 June 2018 Masimo Corporation revenues increased 9% to $424.6M. Net income decreased 7% to $89.5M. Revenues reflect United States segment increase of 10% to $281.2M Europe Middle East and Africa segment increase of 22% to $78.4M. Net income was offset by Selling general and administrative increase of 7% to $142.6M (expense) Research and development increase of 23% to $37.7M (expense).



   Masimo's Neonatal RD SET Pulse Oximetry Sensors Get FDA Nod  2020/01/02 08:14:00 Zacks Investment Research
Masimo (MASI) will cater to the whole prenatal patient population, with the recent FDA clearance within the SET pulse oximetry business.
   Masimo Announces FDA Clearance for Neonatal RD SET® Pulse Oximetry Sensors with Improved Accuracy Specifications  2019/12/30 13:00:00 Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Masimo RD SET® sensors for neonatal patients have received FDA clearance for improved SpO2 accuracy specifications.
   Masimo (MASI) Expands Partnership with Texas-Based Drager  2019/12/20 16:14:00 Zacks Investment Research
Masimo (MASI) sees a slew of developments in recent times.
   Masimo and Dräger Expand Licensing Agreement to Add Masimo Brain Monitoring and Capnography Technologies  2019/12/19 22:00:00 Business Wire
IRVINE, Calif. & LÜBECK, Germany--(BUSINESS WIRE)--Masimo and Dräger are expanding their licensing agreement to add Masimo SedLine®, O3®, and NomoLine® to Dräger patient monitors.
   Here's Why You Should Hold on to Masimo (MASI) Stock Now  2019/11/21 07:08:00 Zacks Investment Research
Masimo (MASI) raises 2019 revenue and EPS guidance.
  マシモ(MASI)を今すぐお持ちください。」 Here's Why You Should Hold on to Masimo (MASI) Stock Now  2019/11/21 07:08:00 Zacks Investment Research
Masimo (MASI) raises 2019 revenue and EPS guidance.
   Masimo Announces CE Marking of Radius Capnography™ for the Root® Patient Monitoring and Connectivity Platform  2019/10/31 08:00:00 Business Wire
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo announces CE marking of Radius Capnography™, a portable capnograph with Bluetooth® that provides seamless, tetherless mainstream capnography.
   Masimo (MASI) Reports Next Week: What You Should Expect  2019/10/23 14:34:01 Zacks Investment Research
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Were Hedge Funds Right About Souring On Masimo Corporation (MASI)?  2019/10/21 13:15:04 ACI Information Group
We at Insider Monkey have gone over 730 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of June 28th. In this article, we look at what those funds think of Masimo Corporation (NASDAQ:MASI
   Masimo (MASI) Boosts O3 Platform With Three New Indices  2019/09/10 07:03:00 Zacks Investment Research
Masimo (MASI) announced the development of three additional indices for O3 Regional Oximetry, thereby improving the O3 platform.
   Hidden Gem Exploration: Smaller-Caps Earning Top Quality Scores - Part 2  2019-05-20
Background In this episode, I would like to continue our journey of hidden gem exploration. Small- and mid-caps are filled with investment opportunities that are often neglected by the public. For great investors, like Warren Buffett, such stocks would most likely not fall into their investa…

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 マシモ MASI Masimo Corporation)


 twitter  (公式ツイッターやCEOツイッターなど)